NEW YORK (GenomeWeb News) – Hologic reported after the close of the market on Monday that revenues for its fiscal third quarter rose 33 percent year over, helped by the inclusion of revenues from its Gen-Probe acquisition.

The Bedford, Mass.-based firm said that for the three months ended June 29, revenues increased to $626.1 million, up from $470.2 a year ago, but narrowly missed the average Wall Street estimate of $626.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.